Press Releases

Apr 19, 2026

Ajmal Hussain

Press Releases

Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712

Molecular Partners AG presented new preclinical data supporting its Switch-DARPin T cell engager MP0632 for solid tumors co-expressing MSLN and EpCAM, demonstrating tumor regression with a favorable safety profile. Additionally, the company showcased the molecular characteristics of MP0712, a Radio-DARPin candidate in an ongoing US Phase 1/2a trial…

MOLN

Apr 18, 2026

Derek Hwang

Press Releases

Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting

Revolution Medicines, Inc. presented updated Phase 1 clinical data for zoldonrasib, an oral targeted inhibitor for KRAS G12D non-small cell lung cancer (NSCLC), showing favorable safety and encouraging efficacy results including a 52% objective response rate and prolonged progression-free survival. These results support further clinical development…

RVMD

Apr 18, 2026

Maya Rios

Press Releases

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

Pliant Therapeutics announced updated Phase 1 trial data demonstrating significant antitumor activity of PLN-101095, an oral integrin inhibitor, combined with pembrolizumab in patients with immune checkpoint inhibitor-refractory advanced solid tumors. Confirmed tumor responses showed an average maximum reduction of 89%, with median treatment durati…

PLRX

Apr 18, 2026

Hana Yamamoto

Press Releases

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP

argenx announced new Phase 3 data at AAN 2026 demonstrating that VYVGART, their biologic therapy, significantly improves symptoms in ocular myasthenia gravis, generalized myasthenia gravis regardless of antibody status, and early-stage CIDP patients. Additional studies showed positive results in adolescent patients and ongoing trials support expand…

ARGX

Apr 17, 2026

Ajmal Hussain

Press Releases

B2Gold Reports Fire-Related Incident to the Crushing Circuit at the Goose Mine

B2Gold announced a fire at the crushing circuit of its Goose Mine on April 16, 2026. Emergency procedures were promptly executed, extinguishing the fire without injuries or operational halts. The fire was localized to the secondary crusher screen and feed belt. The company is investigating the cause and assessing any operational impact, with mining…

BTO

Apr 17, 2026

Hana Yamamoto

Press Releases

RedCloud Holdings Plc Receives Notice Regarding Minimum Bid Price Requirement

RedCloud Holdings plc disclosed that Nasdaq has notified the company it does not meet the minimum $1 bid price requirement. RedCloud has 180 days to regain compliance or risk delisting, with a possible additional 180-day extension. The company is focused on its commercial strategy and aims to restore compliance within the given period.

RCT

Apr 17, 2026

Leila Farooq

Press Releases

Statement from American Airlines

American Airlines Group Inc. issued a statement affirming no interest in merging with United Airlines, citing concerns over competition and consumer impact. The company expressed appreciation for the current administration's support of the aviation industry and emphasized its commitment to executing its strategic objectives independently.

AAL

Apr 17, 2026

Maya Rios

Press Releases

Arbe Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Arbe Robotics Ltd., traded on Nasdaq under the ticker ARBE, announced that it received a notification from Nasdaq's Listing Qualifications Department indicating the company failed to meet the minimum bid price requirement of $1 per share for 30 consecutive business days. The company has 180 days to regain compliance or potentially face delisting, w…

ARBE

Apr 17, 2026

Avery Klein

Press Releases

Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC

Callan JMB Inc., a NASDAQ-listed integrative logistics company specializing in healthcare and emergency management supply chains, has been named in a lawsuit by Eddie Patent Holdings LLC. The company is reviewing the claims and believes them to be without merit. It emphasized that the pending litigation does not affect its operations or growth init…

CJMB

Apr 17, 2026

Derek Hwang

Press Releases

Sonoco To Report First Quarter 2026 Results

Sonoco Products Company (NYSE: SON), a global leader in sustainable packaging, will report its first quarter 2026 financial results on April 21, 2026, followed by a conference call on April 22. The company highlights strong sustainability credentials and recognition in 2026 as one of the world's and America's most admired companies.

SON

Apr 17, 2026

Nina Shah

Press Releases

SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders

SEALSQ Corp, a Nasdaq-listed company specializing in post-quantum technology including semiconductors and PKI solutions, announced its 2026 Annual General Meeting to be held on May 7, 2026 in Miami, Florida. The meeting will cover re-election of board members, recent financial and operational performance, and the company's strategic outlook. Shareh…

LAES

Apr 17, 2026

Sofia Navarro

Press Releases

Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting

Theriva Biologics announced new tumor response, biomarker, and subgroup analyses from its VIRAGE Phase 2b clinical trial evaluating VCN-01 combined with gemcitabine/nab-paclitaxel in metastatic pancreatic cancer patients. The data, to be presented at AACR 2026, reinforce VCN-01's immune-mediated mode of action and demonstrate improved outcomes, inc…

TOVX

Apr 17, 2026

Nina Shah

Press Releases

VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE

Value Line, Inc. announced a 7.7% increase in its quarterly dividend to $0.35 per share ($1.40 annualized), reflecting its 12th consecutive annual dividend increase. The dividend is payable on May 12, 2026, to shareholders of record as of April 27, 2026. The company provides a broad range of investment research products and services, including equi…

VALU

Apr 17, 2026

Caleb Monroe

Press Releases

Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

Adagene Inc. presented new clinical data at AACR 2026 demonstrating that their masked anti-CTLA-4 therapy muzastotug, when combined with immunotherapies like atezolizumab and bevacizumab or pembrolizumab and fruquintinib, shows significantly improved overall response rates and manageable safety profiles in advanced hepatocellular carcinoma and micr…

ADAG

Apr 17, 2026

Marcus Reed

Press Releases

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

NEXGEL, Inc. has rescheduled its shareholder update conference call from April 23rd to April 21st, 2026 at 4:30 P.M. ET to discuss the Celularity transaction. The company produces healthcare, beauty, and OTC hydrogel products and maintains strategic manufacturing partnerships.

NXGL

Apr 17, 2026

Hana Yamamoto

Press Releases

Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial

Evaxion A/S announced promising phase 2 trial data for its personalized cancer vaccine EVX-01, designed with its AI-Immunology™ platform, showing an 86% success rate in vaccine targets eliciting tumor-specific immune responses. The data, presented at the AACR Annual Meeting, reinforce the platform's capability to select relevant vaccine targets and…

EVAX

Apr 17, 2026

Caleb Monroe

Press Releases

PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma

Immatics announced that a pediatric patient with advanced metastatic nephroblastoma achieved deep and durable remission following an individual experimental treatment using their PRAME-directed T-cell receptor (TCR) therapy. The treatment led to marked regression of metastases in multiple organs and ongoing remission at 6 months, highlighting the p…

IMTX

Apr 17, 2026

Caleb Monroe

Press Releases

New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma

Evaxion A/S announced new data demonstrating its AI-Immunology platform's capability to identify novel endogenous retrovirus-derived antigens as targets for glioblastoma cancer vaccines. Collaborating with Duke University, the company found that integrating these ERV antigens could overcome challenges posed by glioblastoma's low mutational burden, …

EVAX

Apr 17, 2026

Hana Yamamoto

Press Releases

Sun Communities, Inc. Announces Date for First Quarter 2026 Earnings Release and Conference Call

Sun Communities, Inc., a REIT specializing in manufactured housing and RV communities, will release its Q1 2026 operating results after market close on April 27, 2026, followed by a conference call the next day. The company manages a large portfolio of over 500 developed properties across the U.S., Canada, and the U.K.

SUI

Apr 17, 2026

Derek Hwang

Press Releases

Kaltura to Showcase Agentic Revenue Engagement Platform at Adobe Summit 2026, Demonstrating How Agentic AI Avatars and Content Intelligence Turn Static ABM Pages Into Real-Time Conversations

Kaltura, Inc. premiered its Agentic Revenue Engagement platform at Adobe Summit 2026, combining its AI-powered video and avatar technology with PathFactory's content intelligence and journey orchestration. The platform enables real-time conversational experiences within Adobe Experience Manager, transforming static ABM pages into adaptive, personal…

KLTR

Apr 17, 2026

Sofia Navarro

Press Releases

The York Water Company Announces Closing of Its Common Stock Public Offering

The York Water Company has closed its public offering of 1,521,739 common shares at $28.50 per share, raising net proceeds of approximately $41.4 million. The funds are intended for general corporate purposes, including capital investments, debt repayment, and potential acquisitions. The offering was managed by Huntington Capital Markets and Seapor…

YORW

Apr 17, 2026

Sofia Navarro

Press Releases

Fitness Champs Holdings Limited Announces Pricing of $5 Million Public Offering

Fitness Champs Holdings Limited, a Singapore-based aquatic sports education provider listed on NASDAQ under the ticker FCHL, announced the pricing of a best-efforts public offering to raise approximately $5 million. The offering consists of 3,225,000 units priced at $1.55 each, with units consisting of Class A ordinary shares or pre-funded warrants…

FCHL

Apr 17, 2026

Derek Hwang

Press Releases

MOZAYYX Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 20, 2026

MOZAYYX Acquisition Corp. revealed that beginning April 20, 2026, holders of its IPO units will be able to separately trade the Class A ordinary shares and warrants comprising the units on the NYSE under the symbols MZYX and MZYX.WS respectively. The company operates as a blank check firm aiming to acquire businesses in high-growth sectors such as …

MZYX

Apr 17, 2026

Hana Yamamoto

Press Releases

Odysight.ai Signs Commercial Collaboration Agreement with GACI Technologies to Expand AI-Powered Predictive Maintenance into the French Aerospace and Defense Market

Odysight.ai Inc., a U.S.-listed company specializing in AI/ML visual sensing for predictive and condition-based maintenance, has entered into a commercial collaboration agreement with French aerospace and defense firm GACI Technologies. The partnership aims to bring Odysight.ai's AI-driven predictive maintenance systems to France's advanced aerospa…

ODYS

Apr 17, 2026

Hana Yamamoto

Press Releases

Stellantis to Announce First Quarter 2026 Financial Results on April 30

Stellantis N.V. announced it will release its first quarter 2026 financial results on April 30, 2026. The company will hold a live audio webcast and conference call for investors and analysts to discuss the results. Presentation materials will be made available on their website.

STLA